Sort
89,613 grants matching “depression”
Repurposing FDA-approved oxytocin to treat opioid-induced respiratory depression
$2,104,389David Mendelowitz · George Washington University · UG3 · FY2025 · DA
A multi-modal wireless oscillator array for high-resolution mapping of neurovascular coupling
$2,102,537Chunqi Qian · Michigan State University · RF1 · FY2022 · NS
Detroit Research on Cancer Survivors (Detroit ROCS)
$2,102,386Ann G Schwartz · Wayne State University · U01 · FY2019 · CA
Early neurodevelopment origins of anxiety
$2,102,353Richard J Davidson · University Of Wisconsin-Madison · P50 · FY2015 · MH
Enduring Effects of Early-Life Serotonin Signaling
$2,101,875Randy D Blakely · Vanderbilt University · P50 · FY2014 · MH
Enduring Effects of Early-Life Serotonin Signaling
$2,101,874Randy D Blakely · Vanderbilt University · P50 · FY2016 · MH
Enduring Effects of Early-Life Serotonin Signaling
$2,101,873Randy D Blakely · Vanderbilt University · P50 · FY2015 · MH
Palliative Care for Quality of Life and Symptom Concerns in Lung Cancer
$2,101,844Betty R Ferrell · Beckman Research Institute/City Of Hope · P01 · FY2012 · CA
Identification of Genes Involved in Major Mood Disorders
$2,101,782Francis J McMahon · National Institute Of Mental Health · ZIA · FY2025 · MH
Early neurodevelopment origins of anxiety
$2,101,392Richard J Davidson · University Of Wisconsin-Madison · P50 · FY2014 · MH
Multiscale Analysis of Immune Responses
$2,101,312Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Avanzando Caminos (Leading Pathways): The Hispanic/Latino Cancer Survivorship Cohort Study.â
$2,100,604Frank J Penedo · University Of Miami Coral Gables · UH3 · FY2025 · CA
Identifying Neural Substrates of Behavior in Drosophila Melanogaster
$2,100,255Benjamin H White · National Institute Of Mental Health · ZIA · FY2021 · MH
Translational Evaluation of PET Radiotracers
$2,100,167Robert Innis · National Institute Of Mental Health · ZIA · FY2023 · MH
Development of an implantable closed-loop system for delivery of naloxone for the prevention of opioid-related overdose deaths
$2,099,135Robert W Gereau · Washington University · UG3 · FY2020 · DA
Early Markers of Alzheimer Disease
$2,098,665Susan Resnick · National Institute On Aging · ZIA · FY2018 · AG
GENETIC APPROACHES TO NEURAL &BEHAVIORAL PLASTICITY
$2,097,508Columbia University Health Sciences · P50 · FY2000 · MH
Development of an implantable closed-loop system for delivery of naloxone for the prevention of opioid-related overdose deaths
$2,096,911Robert W Gereau · Washington University · UG3 · FY2019 · DA
Mouse models of stress disorders and addiction
$2,096,662Andrew Holmes · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2016 · AA
Family Study of Affective and Anxiety Spectrum Disorders
$2,096,438Kathleen R Merikangas · National Institute Of Mental Health · ZIA · FY2020 · MH
Addressing Alzheimer's Disease and Related Dementias Disparities: The American Indigenous Cognitive Assessment (AMICA) Project
$2,094,019Kristen Jacklin · University Of Minnesota · R01 · FY2024 · AG
9/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U MICHIGAN
$2,093,912Mary M Heitzeg · University Of Michigan At Ann Arbor · U01 · FY2022 · DA
Introducing Cellular Aging in Human iPS Cells to Investigate Alzheimer Pathogenesis
$2,093,750Hong Zhang · Univ Of Massachusetts Med Sch Worcester · RF1 · FY2017 · AG
PSYCHOSOCIAL CONTRIBUTORS TO HEALTH AND ILLNESS
$2,092,060Carol D. Ryff · University Of Wisconsin-Madison · P01 · FY2011 · AG
Genetic Neurobiology Of Drosophila
$2,091,374Howard A Nash · National Institute Of Mental Health · Z01 · FY2007 · MH